Safety of erlotinib treatment in outpatients with previously treated non-small-cell lung cancer in Japan
Hiroki NagaiShiro TanakaMiyuki NiimiNanae SeoTakahiko SasakiHiroshi DateMichiaki MishimaHiroyasu YasudaKazuhiro Yanagihara
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
16
5
560
567
10.1007/s10147-011-0228-0
https://doi.org/10.1007/s10147-011-0228-0https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000295846300017&DestApp=WOS_CPL